Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists

4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists

US Patent 6423725 · Granted Jul 23, 2002

Estimated economic value: $298,656,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Scintillator array, method for manufacturing scintillator array, radiation detec2025
Plasma processing apparatus and lid member2025
Tetrahydroquinoline derivatives as P2X7 receptor antagonists2025
Heterocyclic derivatives as Nav1.7 and Nav1.8 blockers2024
Fused cyclic urea derivatives as CRHR2 antagonist2023
Amide derivatives as Nav1.7 and Nav1.8 blockers2021
Semiconductor module bonding structure and bonding method2021
Tetrahydroquinoline derivatives as P2X7 receptor antagonists2021
Hard surface detergent composition2021
Biaryloxy derivatives as TTX-S blockers2021
Imaging element, imaging device, and control method2021
Eye-gaze tracker, eye-gaze tracking method, and recording medium2020